Intradural Extramedullary Spinal Cord Tumors and Outcome with Surgical Approach: A Single Centre Retrospective Study
DOI:
https://doi.org/10.37275/bsm.v6i15.693Keywords:
Intradural extramedullary, Spinal tumor, Schwannoma, Meningioma, LaminectomyAbstract
Background: Intradural extramedullary spinal tumor (IDEM) is rare compared to all neoplasms of the central nervous system; however, it is the most common type of primary intraspinal neoplasms. Most tumors are meningioma, schwannoma, and neurofibroma. IDEM tumor has a predilection in women with ages ranging from 40-60 years. This study was conducted to describe the outcome of patients with IDEM tumors after surgery in Dr. Moewardi General Hospital from 2019-2022.
Methods: This retrospective descriptive study was conducted in 2019-2022. Forty-four patients diagnosed with IDEM tumors and who underwent surgical approach were included. The studied variables include age, pathological diagnosis, intervention, and postoperative follow-up.
Results: Most subjects were within the age range of 40-60 years old (52.3%), women (63.6%), and had schwannoma (45.5%), followed by meningioma (25%). Based on gender, both men and women mostly had schwannoma (56.25% and 39.3%, respectively). All subjects underwent tumor excision laminectomy. In the follow-up, most subjects (86.4%) had improved clinical symptoms after surgery.
Conclusion: Intradural extramedullary spinal tumors mostly occur in women 40-60 years old, and schwannoma and meningioma are the most frequent types. Laminectomy intervention can provide clinical symptom improvement in most patients.
Authors
- Dea Alberta Setiawati1*
- Hanis Setyono2
- 1Resident, Department of Surgery, Universitas Sebelas Maret/Dr. Moewardi General Hospital, Surakarta, Indonesia
- 2Neurosurgeon, Department of Neurosurgery, Universitas Sebelas Maret/Dr. Moewardi General Hospital, Surakarta, Indonesia
Corresponding author Dea Alberta Setiawati — dea.alberta@gmail.com
Article history
- Submitted
- Accepted
- Published
Downloads
Published
Issue
Section
License
Copyright and licensing
Copyright in each article remains with the author(s). Authors grant Bioscientia Medicina: Journal of Biomedicine and Translational Research a non-exclusive right of first publication and the right to identify itself as the original publisher. No exclusive transfer of copyright is required.
All articles are published under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (CC BY-NC-SA 4.0): https://creativecommons.org/licenses/by-nc-sa/4.0/. Users may copy, redistribute, remix, transform, and build upon the material for non-commercial purposes, provided appropriate attribution is given, a link to the license is supplied, changes are indicated, and adaptations are distributed under the same license.
The license applies to the article's scholarly content unless a credit line states otherwise. Third-party material may be subject to separate rights. Authors retain patent, trademark, moral, and research-data rights. The copyright year follows the article's publication date.
